Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 2/20 | 0.43 |
| ▸ | FEN1 | P39748 | 5/20 | 0.40 |
| ▸ | ALOX5AP | P20292 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 4/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.38 |
| ▸ | HPGDS | O60760 | 1/20 | 0.38 |
| ▸ | ALKBH2 | Q6NS38 | 1/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.37 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.36 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.36 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.36 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27835961 | 0.81 | ALKBH2 (0.45) | BTKNPC1RAB9ATGFBR1HPGDS | |
| SCHEMBL28484188 | 0.80 | ALOX5AP (0.40) | FEN1ALOX5APNPC1RAB9ATGFBR1 | |
| SCHEMBL21638790 | 0.76 | SCN9A (0.41) | BTKHPGDSALKBH2EGLN1 | |
| SCHEMBL31322788 | 0.73 | MAPK14 (0.49) | BTKNPC1RAB9ATGFBR1HPGDS | |
| SCHEMBL31013160 | 0.72 | BTK (0.42) | BTKHPGDSALKBH2EGLN1MAP4K4 | |
| SCHEMBL2729239 | 0.72 | ACKR3 (0.43) | BTKNPC1RAB9AHPGDSALKBH2 | |
| SCHEMBL21065542 | 0.72 | ALKBH2 (0.37) | BTKNPC1RAB9ATGFBR1HPGDS | |
| SCHEMBL1555170 | 0.69 | BCAT2 (0.61) | FEN1ALOX5APNPC1RAB9A | |
| SCHEMBL2190049 | 0.69 | ALKBH2 (0.74) | NPC1RAB9AHPGDSALKBH2EGLN1 | |
| SCHEMBL29435113 | 0.69 | BCAT2 (0.61) | FEN1ALOX5APNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101908-A1 | MIXTURES FOR FUNGAL CONTROL IN SOYBEANS | CORTEVA AGRISCIENCE LLC (US) | 2026-05-15 | — | — | WO | disclosed |
| WO-2026101906-A1 | MIXTURES FOR FUNGAL CONTROL IN CORN | CORTEVA AGRISCIENCE LLC (US) | 2026-05-15 | — | — | WO | disclosed |
| WO-2026101907-A1 | MIXTURES FOR FUNGAL CONTROL IN CEREALS | CORTEVA AGRISCIENCE LLC (US) | 2026-05-15 | — | — | WO | disclosed |
| EP-3058822-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING PROTHIOCONAZOLE AND FLUXAPYROXAD FOR CONTROLLING BEET DISEASES | Bayer Intellectual Property GmbH (DE) | 2016-08-24 | — | — | EP | disclosed |
| US-20120027741-A1 | PESTICIDE COMPOSITION COMPRISING A TETRAZOLYLOXIME DERIVATIVE AND A FUNGICIDE OR AN INSECTICIDE ACTIVE SUBSTANCE | BAYER CROPSCIENCE AG (DE) | 2012-02-02 | — | — | US | disclosed |
| EP-2176229-A1 | NOVEL CRYSTALLINE FORM OF 3-(DIFLUORMETHYL)-1-METHYL-N -(3',4',5'-TRIFLUOR[1,1'-BIPHENYL]-2-YL)-1H-PYRAZOL-4-CARBOXAMIDE | BASF SE (DE) | 2010-04-21 | — | — | EP | disclosed |
| WO-2009007344-A1 | NOVEL CRYSTALLINE FORM OF 3-(DIFLUORMETHYL)-1-METHYL-N -(3',4',5'-TRIFLUOR[1,1'-BIPHENYL]-2-YL)-1H-PYRAZOL-4-CARBOXAMIDE | BASF SE (DE) | 2009-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120027741-A1 | PESTICIDE COMPOSITION COMPRISING A TETRAZOLYLOXIME DERIVATIVE AND A FUNGICIDE OR AN INSECTICIDE ACTIVE SUBSTANCE | DDT, TH, PRDX5 | BTK 1574/4885FEN1 2462/4885ALOX5AP 938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.